Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

View All Articles by Mark Lawson

Popular Stories

Free access to BioWorld coronavirus articles
BioWorld
The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...
Today's news in brief
BioWorld
BioWorld briefs for March 2.
COVID-19 test makers are adapting for variants
BioWorld MedTech
As COVID-19 variants have emerged, so have questions about the effectiveness of tests for infection. While the risk of mutations significantly limiting their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech's briefs for March 2.
Celltrion wins first conditional Korean approval for COVID-19 antibody Regkirona
BioWorld
HONG KONG – Celltrion Inc. has received conditional marketing authorization from the Ministry of Food and Drug Safety (MFDS) for its anti-COVID-19 monoclonal...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.